Search Tag: rare diseases

2024 20 Feb

  Individualized therapies and the integration of the patient's perspective are becoming increasingly important.   February 29 is Rare Disease Day. On this occasion, the Austrian pharmaceutical company AOP Orphan Pharmaceuticals GmbH (AOP Health) takes a look at the challenges faced by patients with rare diseases and highlights the trends...Read more

2024 24 Jan

Seasoned leader in drug discovery and development   ‍OrphAI Therapeutics Inc., a clinical-stage biopharmaceutical company developing novel therapeutics for rare diseases the appointment of Jay S. Fine, Ph.D. to its Board of Directors.     Dr. Fine has a strong track record of drug discovery and development leadership in respiratory diseases,...Read more

2023 14 Nov

To ensure the availability of new therapies for rare diseases, a functioning cooperation between the public sector, academic research and research-based companies is crucial. With this in mind, Vienna's City Councilor for Health, Social Affairs and Sport, Peter Hacker, paid the Austrian pharmaceutical company AOP Orphan Pharmaceuticals GmbH ("AOP Health")...Read more